Compare KGC & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KGC | GEHC |
|---|---|---|
| Founded | 1993 | 1892 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Computer Software: Prepackaged Software |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7B | 35.8B |
| IPO Year | 1994 | 2022 |
| Metric | KGC | GEHC |
|---|---|---|
| Price | $31.56 | $69.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $34.75 | ★ $89.75 |
| AVG Volume (30 Days) | ★ 9.6M | 3.2M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.43% | 0.20% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $33.62 | $7.06 |
| Revenue Next Year | $0.81 | $4.50 |
| P/E Ratio | $24.18 | ★ $15.48 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $12.37 | $57.65 |
| 52 Week High | $39.11 | $89.77 |
| Indicator | KGC | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 52.67 | 39.24 |
| Support Level | $30.83 | $69.58 |
| Resistance Level | $38.45 | $74.67 |
| Average True Range (ATR) | 1.28 | 1.76 |
| MACD | 0.48 | 0.28 |
| Stochastic Oscillator | 85.05 | 26.95 |
Kinross Gold is a Canada-based gold producer, producing roughly 2 million gold equivalent ounces in 2025. The company had about a decade of gold reserves at the end of 2025. It operates mines in the Americas and West Africa after selling its low-cost Russian operations in 2022 in response to the invasion of Ukraine. Kinross has historically used acquisitions to fuel expansion into new regions and production growth. In 2022, Kinross purchased the Great Bear project in Canada. If developed as we think likely, it could produce an average of more than 500,000 ounces of gold per year for at least a decade, with its unit cash costs likely in the first quartile of the industry cost curve. Though Great Bear's production is likely to be replacement ounces for falling volumes at other mines.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).